191 related articles for article (PubMed ID: 24136008)
1. Breast cancer multifocality and multicentricity and locoregional recurrence.
Lynch SP; Lei X; Hsu L; Meric-Bernstam F; Buchholz TA; Zhang H; Hortobágyi GN; Gonzalez-Angulo AM; Valero V
Oncologist; 2013; 18(11):1167-73. PubMed ID: 24136008
[TBL] [Abstract][Full Text] [Related]
2. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
Yerushalmi R; Tyldesley S; Woods R; Kennecke HF; Speers C; Gelmon KA
Ann Oncol; 2012 Apr; 23(4):876-81. PubMed ID: 21810730
[TBL] [Abstract][Full Text] [Related]
3. Local Control of Breast Conservation Therapy versus Mastectomy in Multifocal or Multicentric Breast Cancer: A Systematic Review and Meta-Analysis.
Fang M; Zhang X; Zhang H; Wu K; Yu Y; Sheng Y
Breast Care (Basel); 2019 Aug; 14(4):188-193. PubMed ID: 31558892
[TBL] [Abstract][Full Text] [Related]
4. Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer.
Patani N; Carpenter R
Breast J; 2010; 16(3):222-32. PubMed ID: 20565467
[TBL] [Abstract][Full Text] [Related]
5. Multifocality and multicentricity in breast cancer and survival outcomes.
Lynch SP; Lei X; Chavez-MacGregor M; Hsu L; Meric-Bernstam F; Buchholz TA; Zhang A; Hortobagyi GN; Valero V; Gonzalez-Angulo AM
Ann Oncol; 2012 Dec; 23(12):3063-3069. PubMed ID: 22776706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes of breast conserving therapy in multifocal and unifocal invasive breast cancer.
Chung AP; Huynh K; Kidner T; Mirzadehgan P; Sim MS; Giuliano AE
J Am Coll Surg; 2012 Jul; 215(1):137-46; discussion 146-7. PubMed ID: 22608402
[TBL] [Abstract][Full Text] [Related]
7. "Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases".
Neri A; Marrelli D; Megha T; Bettarini F; Tacchini D; De Franco L; Roviello F
BMC Surg; 2015 Jan; 15(1):1. PubMed ID: 25586679
[TBL] [Abstract][Full Text] [Related]
8. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
[TBL] [Abstract][Full Text] [Related]
9. Increased lymph node positivity in multifocal and multicentric breast cancer.
Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers.
Kadioğlu H; Özbaş S; Akcan A; Soyder A; Soylu L; Koçak S; Cantürk NZ; Tükenmez M; Müslümanoğlu M
World J Surg Oncol; 2014 Aug; 12():266. PubMed ID: 25143016
[TBL] [Abstract][Full Text] [Related]
11. Conservative surgery for multifocal/multicentric breast cancer.
Nijenhuis MV; Rutgers EJ
Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
[TBL] [Abstract][Full Text] [Related]
12. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Multifocal and Multicentric Breast Cancers.
Kanumuri P; Hayse B; Killelea BK; Chagpar AB; Horowitz NR; Lannin DR
Ann Surg Oncol; 2015 Aug; 22(8):2475-82. PubMed ID: 25805233
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and outcomes of patients with multifocal/multicentric and unifocal breast cancer.
Djordjevic-Jovanovic L; Karanikolic A; Bojic T; Pesic I; Djordjevic M; Marinkovic M
J BUON; 2017; 22(3):652-657. PubMed ID: 28730770
[TBL] [Abstract][Full Text] [Related]
15. Genomic prediction of locoregional recurrence after mastectomy in breast cancer.
Cheng SH; Horng CF; West M; Huang E; Pittman J; Tsou MH; Dressman H; Chen CM; Tsai SY; Jian JJ; Liu MC; Nevins JR; Huang AT
J Clin Oncol; 2006 Oct; 24(28):4594-602. PubMed ID: 17008701
[TBL] [Abstract][Full Text] [Related]
16. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.
Moo TA; McMillan R; Lee M; Stempel M; Ho A; Patil S; El-Tamer M
Ann Surg Oncol; 2014 May; 21(5):1569-74. PubMed ID: 24488216
[TBL] [Abstract][Full Text] [Related]
17. Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.
Nagao T; Kinoshita T; Tamura N; Hojo T; Morota M; Kagami Y
Breast Cancer; 2014 May; 21(3):292-301. PubMed ID: 22890603
[TBL] [Abstract][Full Text] [Related]
18. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
19. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Breast Cancer Patients with T1-2 Tumors and 1-3 Positive Lymph Nodes Treated with or without Postmastectomy Radiation Therapy.
Gilmore RC; Sebai ME; Psoter KJ; Prasath V; Siotos C; Broderick KP; Jacobs LK; Harvey SC; Habibi M
Sci Rep; 2020 Jun; 10(1):9887. PubMed ID: 32555240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
